Research Article
Network Pharmacology-Based Approach to Revealing Biological Mechanisms of Qingkailing Injection against IschemicStroke: Focusing on Blood-Brain Barrier
Figure 6
QKL protected tight junction degeneration and inhibited HIF-1α and MMP-9 activation. (a–e) Expression of occludin, ZO-1, claudin-5, and VE-cadherin was analyzed by western blotting and corresponding quantitative data. (a, f, g) Expression of HIF-1α and MMP-9 was analyzed by western blotting and corresponding quantitative data. Data are reported as means ± SEM. vs. Sham group, vs. Ischemia group (n = 6 per group).
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |